<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-12T01:04:57Z</responseDate>
  <request identifier="oai:figshare.com:article/34047643" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34047643</identifier>
        <datestamp>2026-10-01T17:26:15Z</datestamp>
        <setSpec>category_4</setSpec>
        <setSpec>category_12</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_873</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_134</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_1</setSpec>
        <setSpec>month_year_10_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;The effect of different doses of crocin and orlistat administration on serum liver enzyme levels in the studied groups.&lt;/p&gt;</dc:title>
          <dc:creator>Hossain Rezayee (25157659)</dc:creator>
          <dc:creator>Mohammad Ali Fahmidehkar (25157662)</dc:creator>
          <dc:creator>Farimah Beheshti (4791291)</dc:creator>
          <dc:creator>Mohsen Ghoryani (25157665)</dc:creator>
          <dc:creator>Yaser Yousefpoor (25157668)</dc:creator>
          <dc:creator>Dawood Hossaini (25157671)</dc:creator>
          <dc:creator>Davod Ilbeigi (25157674)</dc:creator>
          <dc:subject>Biochemistry</dc:subject>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Chemical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Virology</dc:subject>
          <dc:subject>containing seven rats</dc:subject>
          <dc:subject>confirmed marked improvement</dc:subject>
          <dc:subject>alkaline phosphatase levels</dc:subject>
          <dc:subject>increased hepatic malondialdehyde</dc:subject>
          <dc:subject>xlink "&gt; forty</dc:subject>
          <dc:subject>present study demonstrate</dc:subject>
          <dc:subject>liver function enzymes</dc:subject>
          <dc:subject>hepatic structural alterations</dc:subject>
          <dc:subject>hepatic lipid accumulation</dc:subject>
          <dc:subject>oxidative stress biomarkers</dc:subject>
          <dc:subject>serum lipid profiles</dc:subject>
          <dc:subject>xlink "&gt; non</dc:subject>
          <dc:subject>xlink "&gt; high</dc:subject>
          <dc:subject>xlink "&gt;</dc:subject>
          <dc:subject>oxidative stress</dc:subject>
          <dc:subject>hepatic steatosis</dc:subject>
          <dc:subject>study aims</dc:subject>
          <dc:subject>lipid profile</dc:subject>
          <dc:subject>histopathological alterations</dc:subject>
          <dc:subject>fatty liver</dc:subject>
          <dc:subject>therapeutic agent</dc:subject>
          <dc:subject>rat model</dc:subject>
          <dc:subject>nitrite concentrations</dc:subject>
          <dc:subject>inflammatory infiltration</dc:subject>
          <dc:subject>histopathological evaluation</dc:subject>
          <dc:subject>four weeks</dc:subject>
          <dc:subject>eight weeks</dc:subject>
          <dc:subject>antioxidant status</dc:subject>
          <dc:subject>animal model</dc:subject>
          <dc:subject>alanine aminotransferase</dc:subject>
          <dc:description>&lt;p&gt;Serum activities of (A) Alanine Aminotransferase (ALT), (B) Aspartate Aminotransferase (AST), and (C) Alkaline Phosphatase (ALP) were measured as biochemical indicators of liver function. Experimental groups (n = 7 per group) were defined as follows: ND, normal diet (control group); HFD, high-fat diet (Fat) group; Cr10, Cr30, and Cr50, animals receiving crocin at doses of 10, 30, and 50 mg/kg body weight, respectively; Orl, animals treated with orlistat. Data are presented as mean ± SD. &lt;sup&gt;##&lt;/sup&gt; p &lt; 0.01, &lt;sup&gt;###&lt;/sup&gt;p &lt; 0.001 compared to the group receiving ND. *p &lt; 0.05, **p &lt; 0.01 and ***p &lt; 0.001 compared to the HFD.&lt;/p&gt;</dc:description>
          <dc:date>2026-10-01T17:26:12Z</dc:date>
          <dc:type>Image</dc:type>
          <dc:type>Figure</dc:type>
          <dc:identifier>10.1371/journal.pone.0357768.g002</dc:identifier>
          <dc:relation>https://figshare.com/articles/figure/_p_The_effect_of_different_doses_of_crocin_and_orlistat_administration_on_serum_liver_enzyme_levels_in_the_studied_groups_p_/34047643</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
